Paper41438744
Development of human mycoplasma vaccines: navigating the IL-17A paradox.
Zhang W and 2 others. Front Immunol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Development of human mycoplasma vaccines: navigating the IL-17A paradox. Papers, record 41438744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41438744
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-17 | Major topic |
| Bacterial Vaccines | Major topic |
| Mycoplasma Infections | Major topic |
| Vaccine Development | Major topic |
| Mycoplasma | Major topic |
| Humans | |
| Animals |
Source PubMed
References106
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31021703 | RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs. | Hum Vaccin Immunother | 2019 | https://conductscience.org/library/papers/31021703 | PubMed |
| 2 | 12065506 | Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. | Infect Immun | 2002 | https://conductscience.org/library/papers/12065506 | PubMed |
| 3 | 41012172 | Adjuvant Mucosal Strategies Confer Safe and Effective Immunity Against Mycoplasma pneumoniae and Overcome Vaccine-Associated Enhanced Lung Pathology. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012172 | PubMed |
| 4 | 23001692 | Mycoplasma pneumoniae extract induces an IL-17-associated inflammatory reaction in murine lung: implication for mycoplasmal pneumonia. | Inflammation | 2013 | https://conductscience.org/library/papers/23001692 | PubMed |
| 5 | 39681568 | Pathobiont-induced suppressive immune imprints thwart T cell vaccine responses. | Nat Commun | 2024 | https://conductscience.org/library/papers/39681568 | PubMed |
| 6 | 39499730 | Suppressing neutrophil itaconate production attenuates Mycoplasma pneumoniae pneumonia. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39499730 | PubMed |
| 7 | 26837942 | Rare extrapulmonary complications of Mycoplasma pneumoniae infection. | BMJ Case Rep | 2016 | https://conductscience.org/library/papers/26837942 | PubMed |
| 8 | 9145334 | Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. | Immunobiology | 1996 | https://conductscience.org/library/papers/9145334 | PubMed |
| 9 | 8905075 | Molecular biology of mycoplasmas. | Annu Rev Microbiol | 1996 | https://conductscience.org/library/papers/8905075 | PubMed |
| 10 | 25157244 | Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications. | Front Microbiol | 2014 | https://conductscience.org/library/papers/25157244 | PubMed |
| 11 | 11115725 | Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice. | Vaccine | 2000 | https://conductscience.org/library/papers/11115725 | PubMed |
| 12 | 22642685 | Protective efficacy of a Mycoplasma pneumoniae P1C DNA vaccine fused with the B subunit of Escherichia coli heat-labile enterotoxin. | Can J Microbiol | 2012 | https://conductscience.org/library/papers/22642685 | PubMed |
| 13 | 38407218 | Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypes. | Emerg Microbes Infect | 2024 | https://conductscience.org/library/papers/38407218 | PubMed |
| 14 | 29672472 | Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant. | MMWR Morb Mortal Wkly Rep | 2018 | https://conductscience.org/library/papers/29672472 | PubMed |
| 15 | 30396892 | Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae. | Infect Immun | 2019 | https://conductscience.org/library/papers/30396892 | PubMed |
| 16 | 32655548 | Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity. | Front Immunol | 2020 | https://conductscience.org/library/papers/32655548 | PubMed |
| 17 | 38794781 | Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis. | Crit Rev Microbiol | 2025 | https://conductscience.org/library/papers/38794781 | PubMed |
| 18 | 27603754 | Mpn491, a secreted nuclease of Mycoplasma pneumoniae, plays a critical role in evading killing by neutrophil extracellular traps. | Cell Microbiol | 2017 | https://conductscience.org/library/papers/27603754 | PubMed |
| 19 | 19111314 | Vaccines for Mycoplasma diseases in animals and man. | J Comp Pathol | 2009 | https://conductscience.org/library/papers/19111314 | PubMed |
| 20 | 23948467 | Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan. | Microb Pathog | 2013 | https://conductscience.org/library/papers/23948467 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972530 | In silico design of bivalent multi-epitope mRNA vaccine candidates against Mycoplasma pneumoniae and Chlamydia pneumoniae. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42972530 | PubMed |
| 42853493 | Mycoplasma pneumoniae infections in the Post-COVID era: recent advances from pathogenesis to clinical management. | Infection | 2026 | https://conductscience.org/library/papers/42853493 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL17A | 3605 | PubTator's text mining | https://conductscience.org/library/genes/3605 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41438744
GET https://conductscience.org/api/papers/v1/41438744/references?page=2